<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">30486853</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>03</Month>
        <Day>25</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>03</Month>
        <Day>25</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1752-1947</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>12</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2018</Year>
              <Month>Nov</Month>
              <Day>29</Day>
            </PubDate>
          </JournalIssue>
          <Title>Journal of medical case reports</Title>
          <ISOAbbreviation>J Med Case Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Pallister-Hall syndrome with orofacial narrowing and tethered cord: a case report.</ArticleTitle>
        <Pagination>
          <StartPage>354</StartPage>
          <MedlinePgn>354</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">354</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s13256-018-1868-8</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pallister-Hall syndrome is a rare, autosomal dominant, genetic disorder characterized by different congenital abnormalities: hypothalamic hamartoblastoma, bifid or shortened epiglottis, polydactyly, renal anomalies, and imperforate anus.</AbstractText>
          <AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">In this case report, we describe the case of a 13-year-old Lebanese-Armenian boy born with Pallister-Hall syndrome showing newly associated manifestations (orofacial narrowing and tethered cord), and currently showing a spontaneous puberty with normal growth pattern following management with growth hormones.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This case report shows a practical approach to this very rare syndrome, mainly with testosterone and growth hormones, and its follow-up in the long term. Being familiar with such cases may allow improvement of our knowledge for better management in the future.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Hayek</LastName>
            <ForeName>Femia</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pediatrics, Rafic Hariri University Hospital, Bir-Hassan, Jinah, Beirut, Lebanon. femiah@yahoo.fr.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>29</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Med Case Rep</MedlineTA>
        <NlmUniqueID>101293382</NlmUniqueID>
        <ISSNLinking>1752-1947</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>3XMK78S47O</RegistryNumber>
          <NameOfSubstance UI="D013739">Testosterone</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>9002-72-6</RegistryNumber>
          <NameOfSubstance UI="D013006">Growth Hormone</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000015" MajorTopicYN="N">Abnormalities, Multiple</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013006" MajorTopicYN="Y">Growth Hormone</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D020249" MajorTopicYN="Y">Hormone Replacement Therapy</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009436" MajorTopicYN="N">Neural Tube Defects</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D054975" MajorTopicYN="N">Pallister-Hall Syndrome</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
          <QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011627" MajorTopicYN="N">Puberty</DescriptorName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013739" MajorTopicYN="Y">Testosterone</DescriptorName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Hypothalamic hamartoma</Keyword>
        <Keyword MajorTopicYN="N">Pallister–Hall syndrome</Keyword>
        <Keyword MajorTopicYN="N">Tethered cord</Keyword>
      </KeywordList>
      <CoiStatement>ETHICS APPROVAL AND CONSENT TO PARTICIPATE: Written informed consent was obtained from the patient’s legal guardian for participation. A copy of the written consent is available for review by the Editor-in-Chief of this journal. CONSENT FOR PUBLICATION: Written informed consent was obtained from the patient’s legal guardian for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. COMPETING INTERESTS: The author declares that she has no competing interests. PUBLISHER’S NOTE: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>2</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>11</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>3</Month>
          <Day>26</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30486853</ArticleId>
        <ArticleId IdType="pmc">PMC6262955</ArticleId>
        <ArticleId IdType="doi">10.1186/s13256-018-1868-8</ArticleId>
        <ArticleId IdType="pii">10.1186/s13256-018-1868-8</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Hall JG. The early history of Pallister–Hall syndrome—Buried treasure of a sort. Gene. 2016;589(2):100–103. doi: 10.1016/j.gene.2016.01.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.gene.2016.01.003</ArticleId>
            <ArticleId IdType="pubmed">26768579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Löw M, Moringlane JR, Reif J, Barbier D, Beige G, Kolles H, Kujat C, Zang KD, Henn W. Polysyndactyly and asymptomatic hypothalamic hamartoma in mother and son: a variant of Pallister-Hall syndrome. Clin Genet. 1995;48(4):209–212. doi: 10.1111/j.1399-0004.1995.tb04090.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1399-0004.1995.tb04090.x</ArticleId>
            <ArticleId IdType="pubmed">8591673</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grebe TA, Clericuzio C. Autosomal dominant inheritance of hypothalamic hamartoma associated with polysyndactyly: Heterogeneity or variable expressivity? Am J Med Genet Part A. 1996;66(2):129–137. doi: 10.1002/(SICI)1096-8628(19961211)66:2&lt;129::AID-AJMG2&gt;3.0.CO;2-M.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1096-8628(19961211)66:2&lt;129::AID-AJMG2&gt;3.0.CO;2-M</ArticleId>
            <ArticleId IdType="pubmed">8958318</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hall J, Pallister P, Clarren S, et al.  Congenital hypothalamic hamartoblastoma, hypopituitarism, imperforate anus, and postaxial polydactyly—a new syndrome? Part I: Clinical, causal, and pathogenetic considerations. Am J Med Genet Part A. 1980;7(1):47–74. doi: 10.1002/ajmg.1320070110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.1320070110</ArticleId>
            <ArticleId IdType="pubmed">7211952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biesecker LG, Graham JM., Jr Pallister-Hall syndrome. J Med Genet. 1996;33(7):585. doi: 10.1136/jmg.33.7.585.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jmg.33.7.585</ArticleId>
            <ArticleId IdType="pmc">PMC1050667</ArticleId>
            <ArticleId IdType="pubmed">8818945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Haynes JH, Bagwell CE. Hirschprung’s disease and imperforate anus in Pallister-Hall syndrome: a new association. J Pediatr Surg. 2003;38(9):1411–1412. doi: 10.1016/S0022-3468(03)00411-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0022-3468(03)00411-1</ArticleId>
            <ArticleId IdType="pubmed">14523835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kremer S, Minotti L, Thiriaux A, Grand S, Satre V, Le Bas JF, Kahane P. Epilepsy and hypothalamic hamartoma: look at the hand Pallister-Hall syndrome. Epileptic Disord. 2003;5(1):27–30.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12773293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shimizu A, Shimazaki E, Tooyama K, Mori T, Miyairi Y, Shigeta H. An infant case of Pallister-Hall syndrome treated with hormone replacement. Clin Pediatr Endocrinol. 2002;11(1):29–32. doi: 10.1297/cpe.11.29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1297/cpe.11.29</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verloes A, David A, Ngo L, Bottani A. Stringent delineation of Pallister-Hall syndrome in two long surviving patients: importance of radiological anomalies of the hands. J Med Genet. 1995;32(8):605–611. doi: 10.1136/jmg.32.8.605.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/jmg.32.8.605</ArticleId>
            <ArticleId IdType="pmc">PMC1051634</ArticleId>
            <ArticleId IdType="pubmed">7473651</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McCann E, Fryer AE, Craigie R, Baillie C, Ba’ath ME, Selby A, Biesecker LG. Genitourinary malformations as a feature of the Pallister–Hall syndrome. Clin Dysmorphol. 2006;15(2):75–79. doi: 10.1097/01.mcd.0000184972.76657.e1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.mcd.0000184972.76657.e1</ArticleId>
            <ArticleId IdType="pubmed">16531732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Orphanet. The portal for rare diseases and orphan drugs. Pallister-Hall syndrome. Available from: http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=GB&amp;Expert=672 (Accessed: 05 October 2017).</Citation>
        </Reference>
        <Reference>
          <Citation>Tsurumi H, Ito M, Ishikura K, Hataya H, Ikeda M, Honda M, Nishimura G. Bifid epiglottis: syndromic constituent rather than isolated anomaly. Pediatr Int. 2010;52(5):723–728. doi: 10.1111/j.1442-200X.2010.03096.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1442-200X.2010.03096.x</ArticleId>
            <ArticleId IdType="pubmed">20149127</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ondrey F, Griffith A, Van Waes C, Rudy S, Peters K, McCullagh L, Biesecker LG. Asymptomatic laryngeal malformations are common in patients with Pallister-Hall syndrome. Am J Med Genet A. 2000;94(1):64–67. doi: 10.1002/1096-8628(20000904)94:1&lt;64::AID-AJMG13&gt;3.0.CO;2-D.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/1096-8628(20000904)94:1&lt;64::AID-AJMG13&gt;3.0.CO;2-D</ArticleId>
            <ArticleId IdType="pubmed">10982485</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stevens CA, Ledbetter JC. Significance of bifid epiglottis. Am J Med Genet A. 2005;134(4):447–449. doi: 10.1002/ajmg.a.30659.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ajmg.a.30659</ArticleId>
            <ArticleId IdType="pubmed">15782417</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kraus M, Diu M. Bifid epiglottis in a patient with Pallister-Hall syndrome. Can J Anesth. 2016;63(10):1197–1198. doi: 10.1007/s12630-016-0686-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12630-016-0686-y</ArticleId>
            <ArticleId IdType="pubmed">27339091</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mundlos S, Horn D, Mundlos S, Horn D.  Limb Malformations. Berlin: Springer; 2014. Pallister–Hall Syndrome; pp. 61–62.</Citation>
        </Reference>
        <Reference>
          <Citation>Johnston JJ, Olivos-Glander I, Killoran C, et al.  Molecular and Clinical Analyses of Greig Cephalopolysyndactyly and Pallister-Hall Syndromes: Robust Phenotype Prediction from the Type and Position of GLI3 Mutations. Am J Hum Genet. 2005;76(4):609–622. doi: 10.1086/429346.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/429346</ArticleId>
            <ArticleId IdType="pmc">PMC1199298</ArticleId>
            <ArticleId IdType="pubmed">15739154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biesecker LG. Polydactyly: How many disorders and how many genes: 2010 update. Dev Dyn. 2011;240(5):931–942. doi: 10.1002/dvdy.22609.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/dvdy.22609</ArticleId>
            <ArticleId IdType="pmc">PMC3088011</ArticleId>
            <ArticleId IdType="pubmed">21445961</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Phadke SR, Skandar VH. Polydactyly and genes. Indian J Pediatr. 2010;77:277–281. doi: 10.1007/s12098-010-0033-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12098-010-0033-1</ArticleId>
            <ArticleId IdType="pubmed">20177829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lacerda L da S, Alves ÚD, Zanier JFC, Machado DC, Camilo GB, Lopes AJ. Differential diagnoses of overgrowth syndromes: the most important clinical and radiological disease manifestations. Radiol Res Pract. 2014;2014:947451.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4070411</ArticleId>
            <ArticleId IdType="pubmed">25009745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moon HD, Simpson ME, Li CH, Evans HM. Neoplasms in rats treated with pituitary growth hormone. I Pulmonary and lymphatic tissues. Cancer Res. 1950;10:297–308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15414480</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rogers PC, Komp D, Rogol A, Sabio H. Possible effect of growth hormone on development of acute lymphoblastic leukaemia. Lancet. 1977;2:434–445. doi: 10.1016/S0140-6736(77)90613-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(77)90613-4</ArticleId>
            <ArticleId IdType="pubmed">70647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zadik Z, Estrov Z, Karov Y, Hahn T, Barak Y. The effect of growth hormone and IGF-I on clonogenic growth of hematopoietic cells in leukemic patients during active disease and during remission–a preliminary report. J Pediatr Endocrinol. 1993;6:79–83.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8374694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ogilvy-Stuart AL. Safety of growth hormone after treatment of a childhood malignancy. Horm Res. 1955;44(Suppl 3):73–79.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8719444</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ng ST, Zhou J, Adesanya OO, Wang J, LeRoith D, Bondy CA. Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nat Med. 1997;3:1141–1144. doi: 10.1038/nm1097-1141.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm1097-1141</ArticleId>
            <ArticleId IdType="pubmed">9334728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Varsseveld NC, van Bunderen CC, Franken AA, Koppeschaar HP, van der Lely AJ, Drent ML. Tumor Recurrence or Regrowth in Adults With Nonfunctioning Pituitary Adenomas Using GH Replacement Therapy. J Clin Endocrinol Metab. 2015;100(8):3132–3139. doi: 10.1210/jc.2015-1764.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2015-1764</ArticleId>
            <ArticleId IdType="pubmed">26057181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gittoes NJ, Bates AS, Tse W, Bullivant B, Sheppard MC, Clayton RN, Stewart PM. Radiotherapy for non-function pituitary tumours. Clin Endocrinol. 1998;48:331–337. doi: 10.1046/j.1365-2265.1998.00393.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2265.1998.00393.x</ArticleId>
            <ArticleId IdType="pubmed">9578824</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van den Bergh AC, van den Berg G, Schoorl MA, Sluiter WJ, van der Vliet AM, Hoving EW, Szabó BG, Langendijk JA, Wolffenbuttel BH, Dullaart RP. Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy. Int J Radiat Oncol Biol Phys. 2007;67:863–869. doi: 10.1016/j.ijrobp.2006.09.049.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ijrobp.2006.09.049</ArticleId>
            <ArticleId IdType="pubmed">17197121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loeffler JS, Shih HA. Radiation therapy in the management of pituitary adenomas. J Clin Endocrinol Metab. 2011;96:1992–2003. doi: 10.1210/jc.2011-0251.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1210/jc.2011-0251</ArticleId>
            <ArticleId IdType="pubmed">21525155</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brada M, Rajan B, Traish D, Ashley S, Holmes-Sellors PJ, Nussey S, Uttley D. The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol. 1993;38:571–578. doi: 10.1111/j.1365-2265.1993.tb02137.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2265.1993.tb02137.x</ArticleId>
            <ArticleId IdType="pubmed">8334743</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Graham JM, Jr, Harris M, Frank JE, Little GA, Klein RZ. Congenital hypothalamic hamartoblastoma syndrome: Natural history and genetic implications. Prog Clin Biol Res. 1985;200:163–174.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4080737</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
